APO RESEARCH · REPORT
Non-invasive Glucose Monitoring Device
Non-invasive glucose monitoring device could measure your glucose without hurt your finger. Non-invasive glucose monitoring device refers to the measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from the disease) without drawing blood, puncturing the skin, or causing pain or trauma.In this report, we study both disposable sensors and durable systems.
Product & engineering
Understand the product.
Non-invasive glucose monitoring device could measure your glucose without hurt your finger. Non-invasive glucose monitoring device refers to the measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from the disease) without drawing blood, puncturing the skin, or causing pain or trauma.In this report, we study both disposable sensors and durable systems.
Selected research
Market Structure
Global Non-invasive Glucose Monitoring Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Non-invasive glucose monitoring device could measure your glucose without hurt your finger. Non-invasive glucose monitoring device refers to the measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from the disease) without drawing blood, puncturing the skin, or causing pain or trauma.In this report, we study both disposable sensors and durable systems.
Market is really concentrated. Abbott and DexCom accounted for 54.33% and 47.03% market share in 2019.
This report provides an overview of the global Non-invasive Glucose Monitoring Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Non-invasive Glucose Monitoring Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Non-invasive Glucose Monitoring Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-invasive Glucose Monitoring Device market size, projected growth trends, production technologies, key applications, and end-use industries.
Non-invasive Glucose Monitoring Device Segment by Company
DexCom
Abbott
Cnoga Medical
Integrity Applications
Taiwan Biophotonic
MediWise
GlySens Incorporated
Non-invasive Glucose Monitoring Device Segment by Type
Wearable Devices
Non-wearable Devices
Non-invasive Glucose Monitoring Device Segment by Application
Hospital
Home Care
Other
Non-invasive Glucose Monitoring Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-invasive Glucose Monitoring Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-invasive Glucose Monitoring Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-invasive Glucose Monitoring Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Non-invasive Glucose Monitoring Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-invasive Glucose Monitoring Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-invasive Glucose Monitoring Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Non-invasive Glucose Monitoring Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Wearable Devices
- Non-wearable Devices
Applications
- Hospital
- Home Care
- Other
Companies covered
- DexCom
- Abbott
- Cnoga Medical
- Integrity Applications
- Taiwan Biophotonic
- MediWise
- GlySens Incorporated
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Non-invasive Glucose Monitoring Device Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Non-invasive Glucose Monitoring Device Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Non-invasive Glucose Monitoring Device Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Non-invasive Glucose Monitoring Device Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Non-invasive Glucose Monitoring Device Market Dynamics
- 2.1 Non-invasive Glucose Monitoring Device Industry Trends
- 2.2 Non-invasive Glucose Monitoring Device Industry Drivers
- 2.3 Non-invasive Glucose Monitoring Device Industry Opportunities and Challenges
- 2.4 Non-invasive Glucose Monitoring Device Industry Restraints
3 Non-invasive Glucose Monitoring Device Market by Manufacturers
- 3.1 Global Non-invasive Glucose Monitoring Device Revenue by Manufacturers (2021-2026)
- 3.2 Global Non-invasive Glucose Monitoring Device Sales by Manufacturers (2021-2026)
- 3.3 Global Non-invasive Glucose Monitoring Device Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Non-invasive Glucose Monitoring Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Non-invasive Glucose Monitoring Device Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Non-invasive Glucose Monitoring Device Manufacturers, Product Type & Application
- 3.7 Global Non-invasive Glucose Monitoring Device Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Non-invasive Glucose Monitoring Device Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Non-invasive Glucose Monitoring Device Players Market Share by Revenue in 2025
- 3.8.3 2025 Non-invasive Glucose Monitoring Device Tier 1, Tier 2, and Tier 3
4 Non-invasive Glucose Monitoring Device Market by Type
- 4.1 Non-invasive Glucose Monitoring Device Type Introduction
- 4.1.1 Wearable Devices
- 4.1.2 Non-wearable Devices
- 4.2 Global Non-invasive Glucose Monitoring Device Sales by Type
- 4.2.1 Global Non-invasive Glucose Monitoring Device Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Non-invasive Glucose Monitoring Device Sales by Type (2021-2032)
- 4.2.3 Global Non-invasive Glucose Monitoring Device Sales Market Share by Type (2021-2032)
- 4.3 Global Non-invasive Glucose Monitoring Device Revenue by Type
- 4.3.1 Global Non-invasive Glucose Monitoring Device Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Non-invasive Glucose Monitoring Device Revenue by Type (2021-2032)
- 4.3.3 Global Non-invasive Glucose Monitoring Device Revenue Market Share by Type (2021-2032)
5 Non-invasive Glucose Monitoring Device Market by Application
- 5.1 Non-invasive Glucose Monitoring Device Application Introduction
- 5.1.1 Hospital
- 5.1.2 Home Care
- 5.1.3 Other
- 5.2 Global Non-invasive Glucose Monitoring Device Sales by Application
- 5.2.1 Global Non-invasive Glucose Monitoring Device Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Non-invasive Glucose Monitoring Device Sales by Application (2021-2032)
- 5.2.3 Global Non-invasive Glucose Monitoring Device Sales Market Share by Application (2021-2032)
- 5.3 Global Non-invasive Glucose Monitoring Device Revenue by Application
- 5.3.1 Global Non-invasive Glucose Monitoring Device Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Non-invasive Glucose Monitoring Device Revenue by Application (2021-2032)
- 5.3.3 Global Non-invasive Glucose Monitoring Device Revenue Market Share by Application (2021-2032)
6 Global Non-invasive Glucose Monitoring Device Sales by Region
- 6.1 Global Non-invasive Glucose Monitoring Device Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Non-invasive Glucose Monitoring Device Sales by Region (2021-2032)
- 6.2.1 Global Non-invasive Glucose Monitoring Device Sales by Region (2021-2026)
- 6.2.2 Global Non-invasive Glucose Monitoring Device Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Non-invasive Glucose Monitoring Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Non-invasive Glucose Monitoring Device Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Non-invasive Glucose Monitoring Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Non-invasive Glucose Monitoring Device Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Non-invasive Glucose Monitoring Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Non-invasive Glucose Monitoring Device Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Non-invasive Glucose Monitoring Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Non-invasive Glucose Monitoring Device Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Non-invasive Glucose Monitoring Device Revenue by Region
- 7.1 Global Non-invasive Glucose Monitoring Device Revenue by Region
- 7.1.1 Global Non-invasive Glucose Monitoring Device Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Non-invasive Glucose Monitoring Device Revenue by Region (2021-2026)
- 7.1.3 Global Non-invasive Glucose Monitoring Device Revenue by Region (2027-2032)
- 7.1.4 Global Non-invasive Glucose Monitoring Device Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Non-invasive Glucose Monitoring Device Revenue (2021-2032)
- 7.2.2 North America Non-invasive Glucose Monitoring Device Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Non-invasive Glucose Monitoring Device Revenue (2021-2032)
- 7.3.2 Europe Non-invasive Glucose Monitoring Device Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Non-invasive Glucose Monitoring Device Revenue (2021-2032)
- 7.4.2 Asia-Pacific Non-invasive Glucose Monitoring Device Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Non-invasive Glucose Monitoring Device Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Non-invasive Glucose Monitoring Device Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 DexCom
- 8.1.1 DexCom Company Information
- 8.1.2 DexCom Business Overview
- 8.1.3 DexCom Non-invasive Glucose Monitoring Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 DexCom Non-invasive Glucose Monitoring Device Product Portfolio
- 8.1.5 DexCom Recent Developments
- 8.2 Abbott
- 8.2.1 Abbott Company Information
- 8.2.2 Abbott Business Overview
- 8.2.3 Abbott Non-invasive Glucose Monitoring Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Abbott Non-invasive Glucose Monitoring Device Product Portfolio
- 8.2.5 Abbott Recent Developments
- 8.3 Cnoga Medical
- 8.3.1 Cnoga Medical Company Information
- 8.3.2 Cnoga Medical Business Overview
- 8.3.3 Cnoga Medical Non-invasive Glucose Monitoring Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Cnoga Medical Non-invasive Glucose Monitoring Device Product Portfolio
- 8.3.5 Cnoga Medical Recent Developments
- 8.4 Integrity Applications
- 8.4.1 Integrity Applications Company Information
- 8.4.2 Integrity Applications Business Overview
- 8.4.3 Integrity Applications Non-invasive Glucose Monitoring Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Integrity Applications Non-invasive Glucose Monitoring Device Product Portfolio
- 8.4.5 Integrity Applications Recent Developments
- 8.5 Taiwan Biophotonic
- 8.5.1 Taiwan Biophotonic Company Information
- 8.5.2 Taiwan Biophotonic Business Overview
- 8.5.3 Taiwan Biophotonic Non-invasive Glucose Monitoring Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Taiwan Biophotonic Non-invasive Glucose Monitoring Device Product Portfolio
- 8.5.5 Taiwan Biophotonic Recent Developments
- 8.6 MediWise
- 8.6.1 MediWise Company Information
- 8.6.2 MediWise Business Overview
- 8.6.3 MediWise Non-invasive Glucose Monitoring Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 MediWise Non-invasive Glucose Monitoring Device Product Portfolio
- 8.6.5 MediWise Recent Developments
- 8.7 GlySens Incorporated
- 8.7.1 GlySens Incorporated Company Information
- 8.7.2 GlySens Incorporated Business Overview
- 8.7.3 GlySens Incorporated Non-invasive Glucose Monitoring Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 GlySens Incorporated Non-invasive Glucose Monitoring Device Product Portfolio
- 8.7.5 GlySens Incorporated Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Non-invasive Glucose Monitoring Device Value Chain Analysis
- 9.1.1 Non-invasive Glucose Monitoring Device Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Non-invasive Glucose Monitoring Device Production Mode & Process
- 9.2 Non-invasive Glucose Monitoring Device Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Non-invasive Glucose Monitoring Device Distributors
- 9.2.3 Non-invasive Glucose Monitoring Device Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst